Literature DB >> 27742828

Cytokine-Induced Glucocorticoid Resistance from Eosinophil Activation: Protein Phosphatase 5 Modulation of Glucocorticoid Receptor Phosphorylation and Signaling.

Konrad Pazdrak1,2, Christof Straub1, Rosario Maroto1,2, Susan Stafford1,2, Wendy I White3, William J Calhoun4,2, Alexander Kurosky5,2.   

Abstract

The mechanisms contributing to persistent eosinophil activation and poor eosinopenic response to glucocorticoids in severe asthma are poorly defined. We examined the effect of cytokines typically overexpressed in the asthmatic airways on glucocorticoid signaling in in vitro activated eosinophils. An annexin V assay used to measure eosinophil apoptosis showed that cytokine combinations of IL-2 plus IL-4 as well as TNF-α plus IFN-γ, or IL-3, GM-CSF, and IL-5 alone significantly diminished the proapoptotic response to dexamethasone. We found that IL-2 plus IL-4 resulted in impaired phosphorylation and function of the nuclear glucocorticoid receptor (GCR). Proteomic analysis of steroid sensitive and resistant eosinophils identified several differentially expressed proteins, namely protein phosphatase 5 (PP5), formyl peptide receptor 2, and annexin 1. Furthermore, increased phosphatase activity of PP5 correlated with impaired phosphorylation of the GCR. Importantly, suppression of PP5 expression with small interfering RNA restored proper phosphorylation and the proapoptotic function of the GCR. We also examined the effect of lipoxin A4 on PP5 activation by IL-2 plus IL-4. Similar to PP5 small interfering RNA inhibition, pretreatment of eosinophils with lipoxin A4 restored GCR phosphorylation and the proaptoptotic function of GCs. Taken together, our results showed 1) a critical role for PP5 in cytokine-induced resistance to GC-mediated eosinophil death, 2) supported the dependence of GCR phosphorylation on PP5 activity, and 3) revealed that PP5 is a target of the lipoxin A4-induced pathway countering cytokine-induced resistance to GCs in eosinophils.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27742828      PMCID: PMC5098561          DOI: 10.4049/jimmunol.1601029

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Interleukin-5 inhibits glucocorticoid-mediated apoptosis in human eosinophils.

Authors:  Sven Brode; Neda Farahi; Andrew S Cowburn; Jatinder K Juss; Alison M Condliffe; Edwin R Chilvers
Journal:  Thorax       Date:  2010-08-30       Impact factor: 9.139

2.  Cytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatases.

Authors:  Belaid Bouazza; Kateryna Krytska; Manel Debba-Pavard; Yassine Amrani; Richard E Honkanen; Jennifer Tran; Omar Tliba
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-16       Impact factor: 6.914

3.  Diminished lipoxin biosynthesis in severe asthma.

Authors:  Bruce D Levy; Caroline Bonnans; Eric S Silverman; Lyle J Palmer; Gautham Marigowda; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2005-06-16       Impact factor: 21.405

4.  p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.

Authors:  Aaron L Miller; M Scott Webb; Alicja J Copik; Yongxin Wang; Betty H Johnson; Raj Kumar; E Brad Thompson
Journal:  Mol Endocrinol       Date:  2005-04-07

5.  Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.

Authors:  Vincenzo Brancaleone; Jesmond Dalli; Stefania Bena; Roderick J Flower; Giuseppe Cirino; Mauro Perretti
Journal:  J Immunol       Date:  2011-03-11       Impact factor: 5.422

Review 6.  The effects of glucocorticoids on human eosinophils.

Authors:  R P Schleimer; B S Bochner
Journal:  J Allergy Clin Immunol       Date:  1994-12       Impact factor: 10.793

7.  Modulation of glucocorticoid receptor phosphorylation and transcriptional activity by a C-terminal-associated protein phosphatase.

Authors:  Zhen Wang; Weiwei Chen; Evelyn Kono; Thoa Dang; Michael J Garabedian
Journal:  Mol Endocrinol       Date:  2006-12-21

8.  Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma.

Authors:  Anna Planagumà; Shamsah Kazani; Gautham Marigowda; Oliver Haworth; Thomas J Mariani; Elliot Israel; Eugene R Bleecker; Douglas Curran-Everett; Serpil C Erzurum; William J Calhoun; Mario Castro; Kian Fan Chung; Benjamin Gaston; Nizar N Jarjour; William W Busse; Sally E Wenzel; Bruce D Levy
Journal:  Am J Respir Crit Care Med       Date:  2008-06-26       Impact factor: 21.405

9.  Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: comparison with other glucocorticoids.

Authors:  J B Hagan; H Kita; G J Gleich
Journal:  Clin Exp Allergy       Date:  1998-08       Impact factor: 5.018

10.  Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation.

Authors:  K Pazdrak; B Olszewska-Pazdrak; S Stafford; R P Garofalo; R Alam
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

View more
  15 in total

Review 1.  Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease.

Authors:  Tomomi Toubai; John Magenau
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

2.  Potential Role of Mast Cells in Regulating Corticosteroid Insensitivity in Severe Asthma.

Authors:  Abdulrahman Alzahrani; Aamir Hussain; Fahad Alhadian; Jameel Hakeem; Sana Douaoui; Omar Tliba; Peter Bradding; Yassine Amrani
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Checks and balances: The glucocorticoid receptor and NFĸB in good times and bad.

Authors:  Mandakh Bekhbat; Sydney A Rowson; Gretchen N Neigh
Journal:  Front Neuroendocrinol       Date:  2017-05-11       Impact factor: 8.606

4.  Protein phosphatase 5 and the tumor suppressor p53 down-regulate each other's activities in mice.

Authors:  Jun Wang; Tao Shen; Wuqiang Zhu; Longyu Dou; Hao Gu; Lingling Zhang; Zhenyun Yang; Hanying Chen; Qi Zhou; Edwin R Sánchez; Loren J Field; Lindsey D Mayo; Zhongwen Xie; Deyong Xiao; Xia Lin; Weinian Shou; Weidong Yong
Journal:  J Biol Chem       Date:  2018-09-27       Impact factor: 5.157

5.  Protein phosphatase 1 alpha enhances glucocorticoid receptor activity by a mechanism involving phosphorylation of serine-211.

Authors:  Melanie Patt; Joël Gysi; Nourdine Faresse; John A Cidlowski; Alex Odermatt
Journal:  Mol Cell Endocrinol       Date:  2020-06-22       Impact factor: 4.102

6.  Mechanisms of glucocorticoid resistance in hypereosinophilic syndromes.

Authors:  Kindra Stokes; Pryscilla Yoon; Michelle Makiya; Meheret Gebreegziabher; Nicole Holland-Thomas; JeanAnne Ware; Lauren Wetzler; Paneez Khoury; Amy D Klion
Journal:  Clin Exp Allergy       Date:  2019-10-27       Impact factor: 5.018

Review 7.  Structure and function of the co-chaperone protein phosphatase 5 in cancer.

Authors:  Rebecca A Sager; Natela Dushukyan; Mark Woodford; Mehdi Mollapour
Journal:  Cell Stress Chaperones       Date:  2020-04-02       Impact factor: 3.667

Review 8.  The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease.

Authors:  Gabriel R Fries; Nils C Gassen; Theo Rein
Journal:  Int J Mol Sci       Date:  2017-12-05       Impact factor: 5.923

9.  Diabetes Downregulates Allergen-Induced Airway Inflammation in Mice.

Authors:  Vinicius F Carvalho; Emiliano O Barreto; Ana Carolina S Arantes; Magda F Serra; Tatiana Paula T Ferreira; Yago A P Jannini-Sá; Cory M Hogaboam; Marco A Martins; Patrícia M R Silva
Journal:  Mediators Inflamm       Date:  2018-04-15       Impact factor: 4.711

10.  Eosinophil-to-Monocyte Ratio is a Potential Predictor of Prognosis in Acute Ischemic Stroke Patients After Intravenous Thrombolysis.

Authors:  Yueping Chen; Junli Ren; Naiping Yang; Honghao Huang; Xueting Hu; Fangyue Sun; Tian Zeng; Xinbo Zhou; Wenjing Pan; Jingyu Hu; Beibei Gao; Shunkai Zhang; Guangyong Chen
Journal:  Clin Interv Aging       Date:  2021-05-17       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.